Beijing Winsunny Pharmaceutical CO.LTD (601089) - Total Liabilities
Based on the latest financial reports, Beijing Winsunny Pharmaceutical CO.LTD (601089) has total liabilities worth CN¥1.10 Billion CNY (≈ $161.06 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Beijing Winsunny Pharmaceutical CO.LTD generate cash to assess how effectively this company generates cash.
Beijing Winsunny Pharmaceutical CO.LTD - Total Liabilities Trend (2020–2024)
This chart illustrates how Beijing Winsunny Pharmaceutical CO.LTD's total liabilities have evolved over time, based on quarterly financial data. Check Beijing Winsunny Pharmaceutical CO.LTD liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Beijing Winsunny Pharmaceutical CO.LTD Competitors by Total Liabilities
The table below lists competitors of Beijing Winsunny Pharmaceutical CO.LTD ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chengdu RML Technology Co. Ltd.
SHE:301050
|
China | CN¥927.37 Million |
|
Daou Tech
KO:023590
|
Korea | ₩66.81 Trillion |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055
|
China | CN¥904.54 Million |
|
Paramount Group Inc
NYSE:PGRE
|
USA | $3.90 Billion |
|
Deutsche EuroShop AG
F:DEQ
|
Germany | €2.77 Billion |
|
Focus Technology Co Ltd
SHE:002315
|
China | CN¥1.64 Billion |
|
Qingdao Yunlu Advanced Materials Technology Co. Ltd. A
SHG:688190
|
China | CN¥800.56 Million |
|
Med Life SA
RO:M
|
Romania | RON2.64 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Beijing Winsunny Pharmaceutical CO.LTD's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Beijing Winsunny Pharmaceutical CO.LTD market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Winsunny Pharmaceutical CO.LTD's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
The table below shows the annual total liabilities of Beijing Winsunny Pharmaceutical CO.LTD from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.26 Billion ≈ $184.46 Million |
+17.67% |
| 2023-12-31 | CN¥1.07 Billion ≈ $156.76 Million |
-6.28% |
| 2022-12-31 | CN¥1.14 Billion ≈ $167.26 Million |
+21.87% |
| 2021-12-31 | CN¥937.86 Million ≈ $137.24 Million |
+32.28% |
| 2020-12-31 | CN¥709.01 Million ≈ $103.75 Million |
-- |
About Beijing Winsunny Pharmaceutical CO.LTD
Beijing Foyou Pharma CO.,LTD engages in the research and development, production, and sale of pharmaceutical preparations and medical devices China and internationally. The company provides chemical drugs and traditional chinese medicines. Its products used in cardiovascular kind, chronic kidney disease, skin disease, digestive system, diabetes, neuropsychiatric system kind, mental nervous system… Read more